Kidney injury molecule-1 (KIM-1) and monocyte chemoattractant protein-1 (MCP-1) are among the serum novel biomarkers with emerging roles as potential early diagnostic markers expressed in AKI [21–23]. The gene discussed is CCL2; the disease is acute kidney injury.